Heavy selling. Impact of RNAi therapeutics is sinking in, I believe. Being re-rated in the $4 - $5 range.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025